Skip to content

06938.HK

Suzhou Ribo Life Science Co

HKSE · Healthcare · Biotechnology · CN

HKD 66.05
+2.80%
Ask drillr
  • Jul 2, 2026, 01:19 UTC

    Ribo and Madrigal achieved the first candidate drug nomination milestone in their siRNA partnership for MASH therapies.